Patients with MCC often exhibit oligoclonal lymphocyte-mediated and antibody-mediated immunity against MCC tumor antigens [2–4], with complex arrangements of immune cells, including B cells, CD4+ and CD8+ T cells, macrophages and regulatory T cells [5]. Here, CD4 is linked to neoplasm.